Underexploited Brazilian Cerrado fruits as sources of phenolic compounds for diseases management: A review.

Autor:	Arruda HS; Nutrition and Metabolism Laboratory, Department of Food Science and Nutrition, School of Food Engineering, University of Campinas, Monteiro Lobato Street 80, 13083-862 Campinas, São Paulo, Brazil., Araújo MVL; Nutrition and Metabolism Laboratory, Department of Food Science and Nutrition, School of Food Engineering, University of Campinas, Monteiro Lobato Street 80, 13083-862 Campinas, São Paulo, Brazil., Marostica Junior MR; Nutrition and Metabolism Laboratory, Department of Food Science and Nutrition, School of Food Engineering, University of Campinas, Monteiro Lobato Street 80, 13083-862 Campinas, São Paulo, Brazil.
Jazyk:	angličtina
Zdroj:	Food chemistry. Molecular sciences [Food Chem (Oxf)] 2022 Nov 21; Vol. 5, pp. 100148. Date of Electronic Publication: 2022 Nov 21 (Print Publication: 2022).
DOI:	10.1016/j.fochms.2022.100148
Abstrakt:	The Brazilian Cerrado is home to a large number of native and endemic species of enormous potential, among which we can highlight the cagaita, gabiroba, jatobá-do-cerrado, lobeira, and mangaba. In this review, we report the nutritional and phenolic composition, as well as bioactivities of these five Brazilian Cerrado fruits. The compiled data indicated that these fruits have high nutritional, functional, and economic potential and contribute to the daily intake of macro- and micronutrients, energy, and phenolic compounds by inhabitants of the Cerrado region. Phenolic-rich extracts obtained from these fruits have shown several bioactivities, including antioxidant, anti-inflammatory, antidyslipidemic, antidiabetic, analgesic, anticarcinogenic, hepatoprotective, gastrointestinal protective, and antimicrobial properties. Therefore, these fruits can be explored by the food industry as a raw material to develop food products of high value-added, such as functional foods, and can also be employed as plant sources to obtain bioactive compounds for food, cosmetic, and pharmaceutical purposes. Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (© 2022 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu